"
Team:Dundee/medals
From 2014.igem.org
| (6 intermediate revisions not shown) | |||
| Line 116: | Line 116: | ||
<div class="container"> | <div class="container"> | ||
<div class="jumbotron"> | <div class="jumbotron"> | ||
| - | <h1> | + | <h1>Achievements</h1> |
| - | <p class="lead">... | + | <p class="lead">...OOH Shiny</p> |
</div> | </div> | ||
<br> | <br> | ||
| + | <div class="row"> | ||
| + | <h1>Medals</h1> | ||
| + | <hr> | ||
| + | </div> | ||
<div class="row"> | <div class="row"> | ||
<div class="col-sm-12 col-xs-12"> | <div class="col-sm-12 col-xs-12"> | ||
| - | <h1 style="color:#D4AF37">Gold</h1> | + | <h1 style="color:#D4AF37">Gold ✔</h1> |
✔ We improved the characterization of an existing BioBrick Part or Device (<a href="http://parts.igem.org/Part:BBa_R0079">BBa_R0079</a>, <a href="http://parts.igem.org/Part:BBa_C0179">BBa_C0179</a>) and we have entered this information in the Registry. | ✔ We improved the characterization of an existing BioBrick Part or Device (<a href="http://parts.igem.org/Part:BBa_R0079">BBa_R0079</a>, <a href="http://parts.igem.org/Part:BBa_C0179">BBa_C0179</a>) and we have entered this information in the Registry. | ||
| Line 137: | Line 141: | ||
</p> | </p> | ||
| - | <h1 style="color:#C0C0C0">Silver</h1> | + | <h1 style="color:#C0C0C0">Silver ✔</h1> |
✔ We experimentally validated that at least one new BioBrick Part or Device of your own design and construction <a href="http://parts.igem.org/Part:BBa_K1315007">(BBa_K1315007)</a> works as expected. | ✔ We experimentally validated that at least one new BioBrick Part or Device of your own design and construction <a href="http://parts.igem.org/Part:BBa_K1315007">(BBa_K1315007)</a> works as expected. | ||
| Line 148: | Line 152: | ||
<br/> | <br/> | ||
✔ We submitted this new part <a href="http://parts.igem.org/Part:BBa_K1315007">(BBa_K1315007)</a> to the iGEM Parts Registry. | ✔ We submitted this new part <a href="http://parts.igem.org/Part:BBa_K1315007">(BBa_K1315007)</a> to the iGEM Parts Registry. | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
<br/> | <br/> | ||
<br/> | <br/> | ||
| Line 179: | Line 168: | ||
<p> | <p> | ||
| - | <h1 style="color:#CD7F32">Bronze</h1> | + | <h1 style="color:#CD7F32">Bronze ✔</h1> |
✔ We have registered our <a href="https://igem.org/Team.cgi?year=2014&team_name=Dundee"">Team</a>. | ✔ We have registered our <a href="https://igem.org/Team.cgi?year=2014&team_name=Dundee"">Team</a>. | ||
<br/> | <br/> | ||
Latest revision as of 13:44, 16 November 2014
Achievements
...OOH Shiny
Medals
Gold ✔
✔ We improved the characterization of an existing BioBrick Part or Device (BBa_R0079, BBa_C0179) and we have entered this information in the Registry.✔ We have collaborated with several other iGEM teams.
✔ Our iGEM project involves important questions beyond the bench, relating to safety. We have described an approach that our team has used to address this question.
Silver ✔
✔ We experimentally validated that at least one new BioBrick Part or Device of your own design and construction (BBa_K1315007) works as expected.✔ We documented the characterization of this part in the Main Page section of that Part's/Device's Registry entry.
✔ We submitted this new part (BBa_K1315007) to the iGEM Parts Registry.
✔ Our iGEM project involves important questions beyond the bench, relating to ethics and safety.
Bronze ✔
✔ We have registered our Team.✔ We have completed and submitted the Judging Form.
✔ We have created our team Wiki.
✔ Our Poster and Presentation are prepared and ready for the iGEM Jamboree.
✔ We have clearly attributed any work done by students and distinguished it from work done by others.
✔ We have submitted 11 new BioBrick Parts to the iGEM Registry.
Welcome to Dundee's 2014 Wiki (Site Information)
Cystic Fibrosis is a genetic disease that results in the accumulation of thick mucus in the epithelial linings of the entire body, particularly the respiratory tract. Over the course of a patient’s life, the mucus-lined lung epithelium becomes repeatedly infected with pathogenic bacteria that stimulate an immune response; leading to inflammation, tissue damage, and ultimately, respiratory failure.
The microflora of the Cystic Fibrosis lung changes over time. In childhood, the major coloniser is Staphylococcus aureus, but as the patient matures other bacterial pathogens infect. The later-dominating pathogens, Pseudomonas aeruginosa and Burkholderia cepacia, are very difficult to eradicate and are associated with chronic decline in lung function. Burkholderia is so infectious that patients have to be isolated from one another, and can be denied lung transplants due to the persistence of this bacterium.
It is important, therefore, for medics to monitor and identify the levels of bacteria within the respiratory tract of a Cystic Fibrosis patient. Currently, patients must provide sputum samples and identification of bacteria takes between 72 hours and 2 weeks, by which point the bacteria can be in an antibiotic resistant state.
The Dundee 2014 iGEM project is focused on designing and testing a device that will rapidly and non-invasively identify the bacteria colonising a Cystic Fibrosis patient. Three biosensors will be developed that recognise external signal molecules produced by key bacteria, all of which are known to be in sputum samples of Cystic Fibrosis patients. A quinolone signal (PQS) is produced by Pseudomonas aeruginosa, a Diffusible Signal Factor (DSF) is produced by Stenotrophomonas maltophilia, an organism that is also associated with Cystic Fibrosis lung infection in adults, and BDSF is a related, but chemically distinct molecule that is produced by Burkholderia cepacia.
By engineering signal recognition and signal transduction proteins from these biological systems the Dundee iGEM team want to produce a portable electronic device that will identify infection outside of the clinic, so that patients do not have to travel great distances, and can be used to help health professionals make informed and rapid decisions on antibiotic treatments.
Read this again by clicking on Site Information in the navigation bar!
Bulletin Board (Policy & Practice)
Come look at the poster explaining how we involved the local and national Cystic Fibrosis community in our project, how we listened to people on the front line of the disease and how they affected our project.
School (Project)
Come in and learn about all the parts that make The Lung Ranger. The lab work that we carried out over the summer is explained here in detail, along with the modelling and implementation.
Library (Log Book)
Read about the experience the team has had over the summer. A week by week description of our work, how we carried out that work and some photos of our time together.
Saloon (iGEM community)
Come on in, take a seat and learn how we have interacted with the larger iGem community. Who the team are, who helped them and how we helped others.
College of Life Sciences
With more than 1100 staff and research students and external funding of around £60 million per year, the College of Life Sciences is one of the largest and most productive research institutes in Europe. This reputation is genuinely global and is reflected in the fact that researchers in our laboratories represent no fewer than 62 different nationalities
Division of Mathematics A small friendly Division which offers a lively and modern programme of study at both undergraduate and postgraduate level.We have research groups in Mathematical Biology, Numerical Analysis and Scientific Computing, Magnetohydrodynamics and Applied Analysis.
School of Computing With research areas in Human Centred Computing, Intelligent Systems, Space Technologies and Theory of Computation, the department has an emphasis on development. Furthermore, this department teaches popular undergraduate programs in Applied Computing and Computing Science.
We are a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health. We support the brightest minds in biomedical research and the medical humanities. Our breadth of support includes public engagement, education and the application of research to improve health. We are independent of both political and commercial interests.
